Clinical Trial

Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2024 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study aims to Compare the diagnostic accuracy of the Michigan Neuropathy Screening Instrument (MNSI) (using MNS questionnaire, ,Inspection, vibratory sensation, Ankle reflexes Exam, 10 g monofilament needle examination), routine NCS, and the U/S of the median, posterior tibial, and sural nerves in identifying diabetic peripheral neuropathy in patients recently diagnosed with type 2 diabetes.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06514846
Lead Sponsor Sohag University
Conditions Diabetic Polyneuropathy
Enrollment 100 participants
Start Date 2023-06-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-30